These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22921696)

  • 1. Abnormalities of 24-hour urine composition in first-time and recurrent stone-formers.
    Eisner BH; Sheth S; Dretler SP; Herrick B; Pais VM
    Urology; 2012 Oct; 80(4):776-9. PubMed ID: 22921696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, Body Mass Index, and Gender Predict 24-Hour Urine Parameters in Recurrent Idiopathic Calcium Oxalate Stone Formers.
    Otto BJ; Bozorgmehri S; Kuo J; Canales M; Bird VG; Canales B
    J Endourol; 2017 Dec; 31(12):1335-1341. PubMed ID: 29084490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan.
    Kohjimoto Y; Sasaki Y; Iguchi M; Matsumura N; Inagaki T; Hara I
    Am J Kidney Dis; 2013 Jun; 61(6):923-9. PubMed ID: 23433467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD; Duh QY; Grogan RH; Tran TC; Stoller ML
    Surgery; 2012 Mar; 151(3):477-83. PubMed ID: 21893327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic diagnoses of recurrent stone formers: temporal, geographic and gender differences.
    Huynh LM; Dianatnejad S; Tofani S; Carrillo Ceja R; Liang K; Tapiero S; Jiang P; Youssef RF
    Scand J Urol; 2020 Dec; 54(6):456-462. PubMed ID: 33185135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies of urinary risk factors in urolithiasis].
    Ebisuno S; Kitagawa M; Morimoto S; Miyazaki Y; Minakata S; Yasukawa S; Fukatani T; Ohkawa T
    Hinyokika Kiyo; 1985 Jan; 31(1):1-15. PubMed ID: 3993484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Metabolic changes in 2612 patients with nephrolithiasis].
    del Valle E; Spivacow R; Zanchetta JR
    Medicina (B Aires); 1999; 59(5 Pt 1):417-22. PubMed ID: 10684159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnic background has minimal impact on the etiology of nephrolithiasis.
    Maloney ME; Springhart WP; Ekeruo WO; Young MD; Enemchukwu CU; Preminger GM
    J Urol; 2005 Jun; 173(6):2001-4. PubMed ID: 15879804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic evaluation of recurrent idiopathic calcium stone disease in Portugal].
    Serra A; Domingos F; Salgueiro C; Prata MM
    Acta Med Port; 2004; 17(1):27-34. PubMed ID: 15636725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 24-h urine metabolic profile: is it necessary in all kidney stone formers?
    Abu-Ghanem Y; Shvero A; Kleinmann N; Winkler HZ; Zilberman DE
    Int Urol Nephrol; 2018 Jul; 50(7):1243-1247. PubMed ID: 29876775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    Urology; 2010 Jun; 75(6):1289-93. PubMed ID: 20018350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
    Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
    J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
    [No Abstract]   [Full Text] [Related]  

  • 19. Nephrolithiasis in medullary sponge kidney: evaluation of clinical and metabolic features.
    McPhail EF; Gettman MT; Patterson DE; Rangel LJ; Krambeck AE
    Urology; 2012 Feb; 79(2):277-81. PubMed ID: 22014971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-centered medical therapy for nephrolithiasis.
    Marchini GS; Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Monga M
    Urology; 2013 Mar; 81(3):511-6. PubMed ID: 23452804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.